<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>15</volume><submitter>Efstathiou C</submitter><pubmed_abstract>Human respiratory viruses are the most prevalent cause of disease in humans, with the highly infectious RSV being the leading cause of infant bronchiolitis and viral pneumonia. Responses to type I IFNs are the primary defense against viral infection. However, RSV proteins have been shown to antagonize type I IFN-mediated antiviral innate immunity, specifically dampening intracellular IFN signaling. Respiratory epithelial cells are the main target for RSV infection. In this study, we found RSV-NS1 interfered with the IFN-α JAK/STAT signaling pathway of epithelial cells. RSV-NS1 expression significantly enhanced IFN-α-mediated phosphorylation of STAT1, but not pSTAT2; and neither STAT1 nor STAT2 total protein levels were affected by RSV-NS1. However, expression of RSV-NS1 significantly reduc</pubmed_abstract><journal>Frontiers in immunology</journal><pagination>1395809</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11208467</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Respiratory syncytial virus NS1 inhibits anti-viral Interferon-α-induced JAK/STAT signaling, by limiting the nuclear translocation of STAT1.</pubmed_title><pmcid>PMC11208467</pmcid><pubmed_authors>Kandwal S</pubmed_authors><pubmed_authors>Efstathiou C</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Stevenson NJ</pubmed_authors><pubmed_authors>Molloy EJ</pubmed_authors><pubmed_authors>Fayne D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Respiratory syncytial virus NS1 inhibits anti-viral Interferon-α-induced JAK/STAT signaling, by limiting the nuclear translocation of STAT1.</name><description>Human respiratory viruses are the most prevalent cause of disease in humans, with the highly infectious RSV being the leading cause of infant bronchiolitis and viral pneumonia. Responses to type I IFNs are the primary defense against viral infection. However, RSV proteins have been shown to antagonize type I IFN-mediated antiviral innate immunity, specifically dampening intracellular IFN signaling. Respiratory epithelial cells are the main target for RSV infection. In this study, we found RSV-NS1 interfered with the IFN-α JAK/STAT signaling pathway of epithelial cells. RSV-NS1 expression significantly enhanced IFN-α-mediated phosphorylation of STAT1, but not pSTAT2; and neither STAT1 nor STAT2 total protein levels were affected by RSV-NS1. However, expression of RSV-NS1 significantly reduc</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024</publication><modification>2026-06-01T21:25:39.636Z</modification><creation>2026-05-22T03:08:12.729Z</creation></dates><accession>S-EPMC11208467</accession><cross_references><pubmed>38938568</pubmed><doi>10.3389/fimmu.2024.1395809</doi></cross_references></HashMap>